Trials / Completed
CompletedNCT05190861
Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,032 (actual)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Sepsis is a significant public health concern worldwide, with high morbidity and mortality. With regard to a targeted antimicrobial treatment strategy, the earliest possible pathogen detection is of crucial importance. Until now, culture-based detection methods represent the diagnostic gold standard, although they are characterized by numerous limitations. Culture-independent molecular diagnostic procedures may represent a promising alternative. In particular, droplet digital PCR (ddPCR) is a novel one-step PCR assay that achieves higher accuracy and sensitivity in detecting causing pathogens in patients with bloodstream infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | droplet digital PCR method | The droplet digital PCR method can detect nucleic acids from the most common pathogens (approximately 90%) responsible for BSIs according to Chinet2020 and takes about 4 hours to perform, reporting within the first 24h of suspected sepsis/septic shock. |
| DIAGNOSTIC_TEST | blood culture | Blood culture is a conventional microbiological method of pathogen detection. Results from blood cultures are usually not available until 24 to 72 hours after sampling. |
Timeline
- Start date
- 2021-12-29
- Primary completion
- 2023-12-29
- Completion
- 2023-12-29
- First posted
- 2022-01-13
- Last updated
- 2025-07-11
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05190861. Inclusion in this directory is not an endorsement.